360 related articles for article (PubMed ID: 19691644)
21. Fighting cancer with vaccinia virus: teaching new tricks to an old dog.
Shen Y; Nemunaitis J
Mol Ther; 2005 Feb; 11(2):180-95. PubMed ID: 15668130
[TBL] [Abstract][Full Text] [Related]
22. Oncolytic viral therapies.
Lin E; Nemunaitis J
Cancer Gene Ther; 2004 Oct; 11(10):643-64. PubMed ID: 15286681
[TBL] [Abstract][Full Text] [Related]
23. Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.
Liu TC; Kirn D
Cancer Res; 2007 Jan; 67(2):429-32. PubMed ID: 17234747
[TBL] [Abstract][Full Text] [Related]
24. Remission of Spontaneous Canine Tumors after Systemic Cellular Viroimmunotherapy.
Cejalvo T; Perisé-Barrios AJ; Del Portillo I; Laborda E; Rodriguez-Milla MA; Cubillo I; Vázquez F; Sardón D; Ramirez M; Alemany R; Del Castillo N; García-Castro J
Cancer Res; 2018 Sep; 78(17):4891-4901. PubMed ID: 29991502
[TBL] [Abstract][Full Text] [Related]
25. Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy.
Adelfinger M; Bessler S; Frentzen A; Cecil A; Langbein-Laugwitz J; Gentschev I; Szalay AA
Viruses; 2015 Jul; 7(7):4075-92. PubMed ID: 26205404
[TBL] [Abstract][Full Text] [Related]
26. Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.
Ries SJ; Brandts CH
Drug Discov Today; 2004 Sep; 9(17):759-68. PubMed ID: 15450242
[TBL] [Abstract][Full Text] [Related]
27. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.
Liu TC; Galanis E; Kirn D
Nat Clin Pract Oncol; 2007 Feb; 4(2):101-17. PubMed ID: 17259931
[TBL] [Abstract][Full Text] [Related]
28. Oncolytic vaccinia virus: from bedside to benchtop and back.
Thorne SH
Curr Opin Mol Ther; 2008 Aug; 10(4):387-92. PubMed ID: 18683104
[TBL] [Abstract][Full Text] [Related]
29. A strategy for genetic modification of the spike-encoding segment of human reovirus T3D for reovirus targeting.
van den Wollenberg DJ; van den Hengel SK; Dautzenberg IJ; Cramer SJ; Kranenburg O; Hoeben RC
Gene Ther; 2008 Dec; 15(24):1567-78. PubMed ID: 18650851
[TBL] [Abstract][Full Text] [Related]
30. Future directions: oncolytic viruses.
You L; He B; Xu Z; McCormick F; Jablons DM
Clin Lung Cancer; 2004 Jan; 5(4):226-30. PubMed ID: 14967074
[TBL] [Abstract][Full Text] [Related]
31. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA
Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014
[TBL] [Abstract][Full Text] [Related]
32. Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer.
Naik S; Galyon GD; Jenks NJ; Steele MB; Miller AC; Allstadt SD; Suksanpaisan L; Peng KW; Federspiel MJ; Russell SJ; LeBlanc AK
Mol Cancer Ther; 2018 Jan; 17(1):316-326. PubMed ID: 29158470
[TBL] [Abstract][Full Text] [Related]
33. Naturally occurring viruses for the treatment of cancer.
Roberts MS; Groene WS; Lorence RM; Bamat MK
Discov Med; 2006 Dec; 6(36):217-22. PubMed ID: 17250786
[TBL] [Abstract][Full Text] [Related]
34. RNA viruses as virotherapy agents.
Russell SJ
Cancer Gene Ther; 2002 Dec; 9(12):961-6. PubMed ID: 12522435
[TBL] [Abstract][Full Text] [Related]
35. Gene therapy in the management of oral cancer: review of the literature.
Ayllón Barbellido S; Campo Trapero J; Cano Sánchez J; Perea García MA; Escudero Castaño N; Bascones Martínez A
Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E15-21. PubMed ID: 18167474
[TBL] [Abstract][Full Text] [Related]
36. The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies.
Nguyen TL; Tumilasci VF; Singhroy D; Arguello M; Hiscott J
Cell Microbiol; 2009 Jun; 11(6):889-97. PubMed ID: 19388908
[TBL] [Abstract][Full Text] [Related]
37. Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter.
Hakkarainen T; Rajecki M; Sarparanta M; Tenhunen M; Airaksinen AJ; Desmond RA; Kairemo K; Hemminki A
Clin Cancer Res; 2009 Sep; 15(17):5396-403. PubMed ID: 19706820
[TBL] [Abstract][Full Text] [Related]
38. A potential bat adenovirus-based oncolytic virus targeting canine cancers.
Matsugo H; Kitamura-Kobayashi T; Kamiki H; Ishida H; Sekine W; Takenaka-Uema A; Nakagawa T; Murakami S; Horimoto T
Sci Rep; 2021 Aug; 11(1):16706. PubMed ID: 34408176
[TBL] [Abstract][Full Text] [Related]
39. Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours.
Hwang CC; Igase M; Sakurai M; Haraguchi T; Tani K; Itamoto K; Shimokawa T; Nakaichi M; Nemoto Y; Noguchi S; Coffey M; Okuda M; Mizuno T
Vet Comp Oncol; 2018 Jun; 16(2):229-238. PubMed ID: 29076241
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic viruses.
Chiocca EA
Nat Rev Cancer; 2002 Dec; 2(12):938-50. PubMed ID: 12459732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
